Page last updated: 2024-10-26
valproic acid and Alcohol Problem
valproic acid has been researched along with Alcohol Problem in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Pennybaker, SJ | 1 |
Niciu, MJ | 1 |
Luckenbaugh, DA | 1 |
Zarate, CA | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist[NCT00088699] | Phase 1/Phase 2 | 67 participants (Actual) | Interventional | 2004-07-26 | Completed |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
MADRS Score - Baseline
Antidepressant effects were assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS). It is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. (NCT00088699)
Timeframe: Baseline
Intervention | units on a scale (Mean) |
---|
Ketamine - Healthy Volunteers | 1.17 |
Placebo - Healthy Volunteers | 1.48 |
Ketamine - MDD Patients | 33.83 |
Placebo - MDD Patients | 31.82 |
MADRS Score - Day 1 Following Intervention
Antidepressant effects were assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS). It is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. (NCT00088699)
Timeframe: Day 1
Intervention | units on a scale (Mean) |
---|
Ketamine - Healthy Volunteers | 2.45 |
Placebo - Healthy Volunteers | 0.67 |
Ketamine - MDD Patients | 23.73 |
Placebo - MDD Patients | 30.68 |
Reviews
1 review available for valproic acid and Alcohol Problem